TRAVERSA SERGIO bought RLMD

September 9, 2026 · Form 4 insider transaction

TRAVERSA SERGIO bought 100,000 shares of Relmada Therapeutics, Inc. at $4.18 per share, a transaction worth $418.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
100,000
Price
$4.18
Total value
$418.0K
Role
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 9, 2026
Filing dateSeptember 11, 2026
Shares owned after1,400,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.; Purchase prices range from $4.15 to $4.22 per share, inclusive.

View the original Form 4 on SEC EDGAR